Launxp Biomedical Co (ROCO:6876) Total Liabilities : NT$15.05 Mil (As of Dec. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Launxp Biomedical Co Total Liabilities?

Launxp Biomedical Co's Total Liabilities for the quarter that ended in Dec. 2024 was NT$15.05 Mil.

Launxp Biomedical Co's quarterly Total Liabilities declined from Dec. 2023 (NT$23.19 Mil) to Jun. 2024 (NT$14.00 Mil) but then increased from Jun. 2024 (NT$14.00 Mil) to Dec. 2024 (NT$15.05 Mil).

Launxp Biomedical Co's annual Total Liabilities increased from Dec. 2022 (NT$10.23 Mil) to Dec. 2023 (NT$23.19 Mil) but then declined from Dec. 2023 (NT$23.19 Mil) to Dec. 2024 (NT$15.05 Mil).

Launxp Biomedical Co Total Liabilities Historical Data

The historical data trend for Launxp Biomedical Co's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Launxp Biomedical Co Total Liabilities Chart

Launxp Biomedical Co Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Dec24

Total Liabilities

9.48

8.65

10.23

23.19

15.05

Launxp Biomedical Co Semi-Annual Data
	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Total Liabilities	Get a 7-Day Free Trial				10.23	7.89	23.19	14.00	15.05

Launxp Biomedical Co Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Launxp Biomedical Co's Total Liabilities for the fiscal year that ended in Dec. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	13.934	+	(1.112	+	0
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	15.05

Total Liabilities	=	Total Assets (A: Dec. 2024 )	-	Total Equity (A: Dec. 2024 )
	=	123.911	-	108.865
	=	15.05

Launxp Biomedical Co's Total Liabilities for the quarter that ended in Dec. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	13.934	+	(1.112	+	0
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	15.05

Total Liabilities	=	Total Assets (Q: Dec. 2024 )	-	Total Equity (Q: Dec. 2024 )
	=	123.911	-	108.865
	=	15.05

Launxp Biomedical Co Total Liabilities Related Terms

Thank you for viewing the detailed overview of Launxp Biomedical Co's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Launxp Biomedical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Launxp Biomedical Co Ltd (ROCO:6876) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

10F, No. 51, Section 2, Gongyi Road, Nantun District, Taichung, TWN, 408

Website

https://www.launxp.com

Launxp Biomedical Co Ltd is a company that researches, designs and develops Cancer drug rapid screening platform and Early development evaluation and technology licensing of generic drugs for cancer treatment. The company mainly focuses on the screening of development drugs, formulation of development strategies, project management, planning and execution of regulations and clinical trials, etc.

Launxp Biomedical Co Headlines

No Headlines